Results 241 to 250 of about 387,869 (336)

Hepatitis B Vaccine in national immunization schedule: A preventive step in India

Human Vaccines, 2011
R. Verma, Pardeep Khanna, S. Prinja, M. Rajput, S. Chawla, Mohan Bairwa   +5 more
semanticscholar   +1 more source

Real‐World Study for Mother‐To‐Child Transmission of Hepatitis B in Guangdong Province, 2021–2023

Journal of Viral Hepatitis, Volume 32, Issue 11, November 2025.
ABSTRACT This study aimed to evaluate the status of hepatitis B virus (HBV) mother‐to‐child transmission (MTCT) among infants born to hepatitis B surface antigen (HBsAg)‐positive mothers from 2021 to 2023 and identify key factors influencing HBV MTCT, providing critical insights to inform future HBV prevention strategies.
Tiancheng Xie, Mengyang Su, Min Cai, Tianshuo Zhao, Xiyu Zhang, Sihui Zhang, Mingting Wang, Qingsong Xu, Yujie Cheng, Shuang Gao, Fuqiang Cui   +10 more
wiley   +1 more source

C-Phycocyanin and Phycocyanobilin as a Novel Adjuvant in Hepatitis B Vaccine. [PDF]

Iran J Pharm Res
Abdali N, Tabaripour R, Javadi S, Nasirikenari M, Birjandi M, Siavashi V, Naghavi MR, Hasani Z, Ahmari A, Hanifi H.   +9 more
europepmc   +1 more source

Determinants of timely administration of the birth dose of hepatitis B vaccine in Senegal in 2019: Secondary analysis of the demographic and health survey. [PDF]

PLOS Glob Public Health
Bassoum O, Ba MF, Sougou NM, Sow A, Seck I.   +4 more
europepmc   +1 more source

Update on Hepatitis E Virus Infection 2025: Insights From an International Symposium

Liver International, Volume 45, Issue 11, November 2025.
ABSTRACT Background and Aims The second Hepatitis E Symposium was held as an integral part of the International DFG/DZIF Joint Meeting on Viral Infections of the Liver and the Heart in Berlin. The symposium aimed to provide a comprehensive exploration of hepatitis E virus (HEV) research and bring together clinicians, basic scientists, public health ...
Lara Buchardt, Viet Loan Dao Thi, Reimar Johne, Mathias Ziersch, Dominik Harms, Jörg Hofmann, Katja Dinkelborg, Mara Klöhn, Mira Choi, Jens Kurreck, Heiner Wedemeyer, Daniel Todt   +11 more
wiley   +1 more source

Significant Decline in HCV‐Related Mortality From Liver Cirrhosis and Chronic Liver Disease (2015–2022): A Sentinel Center Study

Liver International, Volume 45, Issue 11, November 2025.
ABSTRACT Background Reducing mortality attributable to hepatitis C virus (HCV) is a key target in the World Health Organization (WHO) HCV elimination strategy. While liver cancer registration in Taiwan includes hepatitis C antibody (anti‐HCV) status, no national registry records viral etiologies for deaths from liver cirrhosis and chronic liver disease
Cheng‐Yeh Yang, Chih‐Yun Lin, Jing‐Houng Wang, Chun‐Yen Lin, Rong‐Nan Chien, Sheng‐Nan Lu   +5 more
wiley   +1 more source

Intralesional acyclovir versus intralesional Hepatitis-B vaccine in treatment of resistant plantar warts: a randomized controlled trial. [PDF]

Arch Dermatol Res
Gharib K, Taha A, Elradi M.
europepmc   +1 more source

Small Molecule Targeting of Atypical p38 Protects Against Viral Infection

The FASEB Journal, Volume 39, Issue 20, 31 October 2025.
Targeting host signaling pathways offers a complementary strategy to direct‐acting antivirals. Small‐molecule modulators of atypical p38 block Hepatitis C virus replication and also inhibit Human Cytomegalovirus. By disrupting virus‐induced p38 activation, these compounds suppress viral RNA replication and protein expression, highlighting atypical p38 ...
Fredejah T. Royer, Jeremy C. Burton, Johnathan Burns, Megan G. Lloyd, Reuben Onwe, Jennifer F. Moffat, Neil J. Grimsey   +6 more
wiley   +1 more source

Hepatitis B vaccine effectiveness among vaccinated children in Africa: a systematic review and meta-analysis. [PDF]

BMC Pediatr
Geta M, Yizengaw E, Manyazewal T.
europepmc   +1 more source

Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations

Medical Journal of Australia, Volume 223, Issue 8, Page 426-436, October 2025.
Abstract Introduction Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, the sixth most common cause of cancer death in Australia. With shifting aetiologies and a growing at‐risk population, consistent routine surveillance recommendations are key to early detection of HCC and improved survival.
Jacob George, Nicole L Allard, Stuart K Roberts, Leon A Adams, Jane Davies, Behzad Hajarizadeh, Jennifer H MacLachlan, Suzanne E Mahady, Rosalie Altus, Catherine Brown, David C Fry, Belinda Greenwood‐Smith, Natali Smud, Patricia C Valery, Nafisa Yussf, Kate Broun, Denise Campbell, Karen Canfell, Chelsea Carle Harrison, Victoria Freeman, Paul Grogan, Catherine Holliday, Suzanne Hughes, Anna Kelly, Cathelijne van Kemenade, Claire Latumahina, Amanda McAtamney, Megan Varlow, Joachim Worthington, Susan Yuill, Eleonora Feletto   +30 more
wiley   +1 more source